Document Detail

Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study.
MedLine Citation:
PMID:  20447066     Owner:  NLM     Status:  MEDLINE    
CONTEXT: One important aspect in the decision to treat or not elderly patients with subclinical hyperthyroidism (SCH) is the risk of progression to overt hyperthyroidism (OH). OBJECTIVE: To define the natural history of endogenous SCH in elderly patients with TSH between 0.1 and 0.4 mIU/l. DESIGN: Prospective study. One hundred and two women aged >or=60 years with persistently low TSH ranging from 0.1 to 0.4 mIU/l and normal free T4 and T3 were studied. Patients using L-T4 or antithyroid drugs, previously treated for hyperthyroidism, with pituitary disease, using corticosteroids, amiodarone, dopaminergic agonists, with atrial fibrillation or heart disease were excluded. Seven patients had Graves' disease, 91 had nodular disease and 4 presented no defined cause. The time of follow-up ranged from 12 to 70 months (median 41 months). RESULTS: Three patients progressed to OH (elevated T4 and/or T3) and four other patients to persistently low TSH (<0.1 mIU/l) in the presence of increase in serum T3 when compared with baseline. These patients were treated. Twenty-four women presented sustained normalization of TSH and none progressed to hypothyroidism. SCH with TSH in the 0.1-0.4 mIU/l range persisted in 71 patients, 4 of them (5.6%) being treated because of the development of atrial fibrillation or heart disease during follow-up. The only independent predictor of progression of SCH was an initial TSH value <0.2 mIU/l. CONCLUSIONS: In elderly patients with endogenous SCH and TSH between 0.1 and 0.4 mIU/l progression to clinical hyperthyroidism is uncommon (approximately 1% per year), spontaneous TSH normalization may occur, and persistence of SCH for many years is the most likely.
Pedro Weslley Rosario
Related Documents :
3417846 - Lasting remissions in patients treated for graves' hyperthyroidism with propranolol alo...
6424976 - Thyroid function in patients with homozygous beta-thalassaemia.
215586 - Triiodothyronine (t3) concentration and therapy in autistic children.
8315436 - Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid a...
2802986 - Esophageal perforation.
21051856 - Multidetector row computed tomography to assess changes in airways linked to asthma con...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical endocrinology     Volume:  72     ISSN:  1365-2265     ISO Abbreviation:  Clin. Endocrinol. (Oxf)     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-05-07     Completed Date:  2010-08-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0346653     Medline TA:  Clin Endocrinol (Oxf)     Country:  England    
Other Details:
Languages:  eng     Pagination:  685-8     Citation Subset:  IM    
Thyroid Department, Endocrinology Service, Minas Gerais, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Disease Progression
Follow-Up Studies
Hyperthyroidism / blood*,  diagnosis,  drug therapy
Middle Aged
Predictive Value of Tests
Prospective Studies
Reference Values
Risk Factors
Thyrotropin / blood*
Thyroxine / blood
Triiodothyronine / blood
Reg. No./Substance:
6893-02-3/Triiodothyronine; 7488-70-2/Thyroxine; 9002-71-5/Thyrotropin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype.
Next Document:  Metabolic cardiovascular disease risk factors and their clustering in subclinical hypothyroidism.